(BTSG) BrightSpring Health - Ratings and Ratios

BrightSpring Health Services, Inc. (NASDAQ:BTSG) is a leading provider of home and community-based healthcare services in the United States. The company operates through two core segments: Pharmacy Solutions and Provider Services. Its platform is designed to deliver comprehensive care, including pharmacy services and clinical support, to Medicare, Medicaid, and insured populations. The Pharmacy Solutions segment offers infused, injectable, and oral medication services, while the Provider Services segment provides patient-centric clinical care, rehabilitation services, and applied behavioral analysis (ABA) therapy. The companys services are delivered in home and community settings, emphasizing accessibility and personalized care.

BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky. Formerly known as Phoenix Parent Holdings Inc., the company rebranded to its current name in May 2021. With a focus on integrating pharmacy and healthcare services, BrightSpring aims to improve health outcomes for vulnerable populations, including those with complex medical needs and developmental disabilities. The companys approach combines clinical expertise with compassionate care, addressing the growing demand for cost-effective, home-based healthcare solutions.

Ticker Symbol: BTSG Exchange: NASDAQ Type: common stock Country Origin: United States GICS Sub Industry: Health Care Services

3-Month Forecast: Based on and , BTSG is expected to experience moderate volatility with potential upside. The stocks SMA 20 of 17.09 and SMA 50 of 18.00 suggest a near-term bullish trend, while the SMA 200 of 16.67 indicates long-term stability. The ATR of 0.86 reflects relatively low volatility. On the fundamental side, the forward P/E of 37.88 signals high growth expectations, though the negative RoE of -1.10 raises concerns about profitability. The P/S ratio of 0.27 suggests undervaluation relative to sales, which could attract investors. Overall, BTSG is likely to see price appreciation driven by its growth prospects, but investors should monitor the companys ability to improve profitability.